Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Subcutaneous Panniculitis-like T-cell Lymphoma with a HAVCR2 Mutation Diagnosed after 10 Years of Treatment with Glucocorticoids and Cyclosporine as Lupus Panniculitis.

Internal medicine (Tokyo, Japan) - 15 May 2023

Yamamoto Yoshiki, Mitsui Asako, Noda Kentaro, Suzuki Yasuo, Sawaki Akihiko, Shinoki Toshihiko, Imai Hiroshi, Miyazaki Kana, Tawara Isao, Nakajima Ayako

Abstract excerpt

Subcutaneous panniculitis-like T cell lymphoma (SPTCL) is a very rare cutaneous T cell lymphoma that has been reported to be associated with autoimmune disorders but is most commonly associated with systemic lupus erythematosus. We herein report a 26-year-old man thought to have lupus panniculitis (LP) treated for 10 years with corticosteroids and cyclosporine. After several relapses with panniculitis, he was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclosporine
Share to Diagnosis, Differential

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucocorticoids

Share to Hepatitis A Virus Cellular Receptor 2

Share to Lymphoma, T-Cell

Share to Neoplasm Recurrence, Local

Share to Panniculitis

Share to Skin Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 36171125
DOI: 10.2169/internalmedicine.0428-22
PMCID: PMC10258092

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Subcutaneous Panniculitis-like T-cell Lymphoma with a HAVCR2 Mutation Diagnosed after 10 Years of Treatment with Glucocorticoids and Cyclosporine as Lupus Panniculitis.PMID 36171125Read ↗

Subcutaneous panniculitis-like T-cell lymphoma in a 14-year-old female homozygous for HAVCR2 mutation.Semantic proximity Read ↗

Genetic profiles and clinical features in subcutaneous panniculitis-like T-cell lymphomas.Semantic proximity Read ↗

Subcutaneous Panniculitis-like T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis Syndrome in Children and Its Essential Role of HAVCR2 Gene Mutation Analysis.Semantic proximity Read ↗

Efficacy of ruxolitinib for HAVCR2 mutation‐associated hemophagocytic lymphohistiocytosis and panniculitis manifestations in childrenSemantic proximity Read ↗

A Case of Pediatric Subcutaneous Panniculitis-like T-cell Lymphoma (SPTCL) presenting as HLHSemantic proximity Read ↗

Unraveling subcutaneous panniculitis-like T-cell lymphoma: An association between subcutaneous panniculitis-like T-cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosis.Semantic proximity Read ↗

Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations.Semantic proximity Read ↗

Ruxolitinib Monotherapy for a Child With HAVCR2 Gene Mutation Associated Subcutaneous Panniculitis-like T-cell Lymphoma: A Case Report.Semantic proximity Read ↗

Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphomaSemantic proximity Read ↗

An investigation of germline variants of HAVCR2 in subcutaneous panniculitis-like T-cell lymphoma and related lesions in a North American population.Semantic proximity Read ↗

Good prognosis of adult hemophagocytic lymphohistiocytosis associated with the germline HAVCR2 mutation.Semantic proximity Read ↗

Case Report: HAVCR2 mutation-associated Hemophagocytic lymphohistiocytosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.